CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cannapharmarx Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cannapharmarx Inc
Suite 3600, 888 3rd Street Sw
Phone: (949) 652-6838p:949 652-6838 CALGARY, AB  T2P 5C5  Canada Fax: (302) 645-1280f:302 645-1280
On 5/3/2024, the Securities and Exchange Commission (SEC) charged BF Borgers CPA PC and its owner, Benjamin F. Borgers, with significant violations of Public Company Accounting Oversight Board (PCAOB) standards across more than 1,500 SEC filings from January 2021 to June 2023. The charges included falsely representing compliance with PCAOB standards to clients, fabricating audit documentation, and inaccurately stating compliance in audit reports. According to the SEC's order, of 369 BF Borgers' clients whose public filings from January 2021 through June 2023 incorporated the firm's audits and reviews, at least 75 percent of the filings incorporated audits and reviews that did not comply with PCAOB standards. The financials in this report may include past audits and reviews conducted by BF Borgers CPA PC that are deemed not compliant with PCAOB standards.
Business Summary
CannaPharmaRX Inc. is a Canada-based cannabis company focused on producing customizable medical cannabis and craft products. The Company operates from its facility in Cremona, AB, Canada, and is able to produce over 6,000 kgs per year. The Company is focused on evaluation, negotiation, acquisition, and development cannabis cultivation projects in Canada. The Company's products include unique genetics, craft products, medical cannabis, its brands and licenses. In addition to medical cannabis, it has also created some craft products. Craft cannabis, also known as craft marijuana, is cannabis that is produced on a small scale by artisanal or independent producers.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes---

Industries
SIC Code Description
0182 Food crops grown under cover

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Director Dominick L.Colvin 53 6/1/2023 4/20/2018
Chief Financial Officer Oliver W.Foeste 10/13/2023 10/13/2023
Chief Operating Officer AndrewSteedman 60 4/23/2019 4/23/2019
3 additional Officers and Directors records available in full report.

Business Names
Business Name
Alternative Medical Solutions, Inc.
Cavion Technologies, Inc
Concord Ventures, Inc.
4 additional Business Names available in full report.

General Information
Number of Employees: 21 (As of 12/31/2023)
Outstanding Shares: 656,725,644 (As of 9/30/2024)
Shareholders: 317
Stock Exchange: OTC
Federal Tax Id: 841472763
Fax Number: (302) 645-1280


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024